Michelino De Laurentiis: Constructive Scientific Dialogue on the Future of Adjuvant Therapy in HR...

Michelino De Laurentiis: Constructive Scientific Dialogue on the Future of Adjuvant Therapy in HR+/HER2– Breast Cancer  Oncodaily

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized ph...

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial  Nature

The Agronomists, Ep 217: Adjuvant selection with Austin Anderson and Jason Deveau - RealAgriculture

The Agronomists, Ep 217: Adjuvant selection with Austin Anderson and Jason Deveau  RealAgriculture

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer - The New England Journal of Med...

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer  The New England Journal of Medicine

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter ...

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial  UroToday

Matrix-M® Adjuvant - Novavax

Matrix-M® Adjuvant  Novavax

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds - Georgia S...

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds  Georgia State University News

An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses - Science | AAAS

An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses  Science | AAAS

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics - Nature

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics  Nature

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer - The New England...

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer  The New England Journal of Medicine

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098...

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial  Nature

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma - The New England J...

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma  The New England Journal of Medicine

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through...

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization  Nature

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization...

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization in mice  Nature

Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patien...

Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model  Nature

3D spectral CT-based fusion model predicts prognosis and postoperative adjuvant chemotherapy bene...

3D spectral CT-based fusion model predicts prognosis and postoperative adjuvant chemotherapy benefit in locally advanced rectal cancer  Nature

Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy sel...

Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma  Nature

Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanc...

Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials | British Journal of Cancer  Nature

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against...

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections  Nature

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopha...

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma  Nature

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–IIIA non-small-cell lung cancer  Nature

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protect...

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic viruses  Nature

World-first library of vaccine-enhancing adjuvants launches - CEPI

World-first library of vaccine-enhancing adjuvants launches  CEPI

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer as...

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer assessed through SEER database analysis  Nature

Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the...

Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial  Nature

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC - The ASCO Post

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC  The ASCO Post

New dual-adjuvant vaccine strategy offers hope in the fight against HIV - News-Medical

New dual-adjuvant vaccine strategy offers hope in the fight against HIV  News-Medical

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer - On...

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer  OncLive

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae ...

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model  Nature

Linking vaccine adjuvant mechanisms of action to function - Science | AAAS

Linking vaccine adjuvant mechanisms of action to function  Science | AAAS

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy - T...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy  The ASCO Post

Shell ondina x as animal vaccine adjuvant - Shell Global

Shell ondina x as animal vaccine adjuvant  Shell Global

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 y...

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial  The Lancet

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and...

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and III Colorectal Cancer  The ASCO Post

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer - The A...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer  The ASCO Post

Adjuvant Pertuzumab Plus Trastuzumab and Chemotherapy Leads to OS Benefit in Early-Stage HER2+ Br...

Adjuvant Pertuzumab Plus Trastuzumab and Chemotherapy Leads to OS Benefit in Early-Stage HER2+ Breast Cancer  OncLive

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy...

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy  The ASCO Post

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer  The ASCO Post

CtDNA-guided adjuvant therapy with atezolizumab improves survival outcomes in patients with muscl...

CtDNA-guided adjuvant therapy with atezolizumab improves survival outcomes in patients with muscle-invasive bladder cancer  Queen Mary University of London

Health Canada Approves Adjuvant Ribociclib for HR+/HER2– Early Breast Cancer - OncLive

Health Canada Approves Adjuvant Ribociclib for HR+/HER2– Early Breast Cancer  OncLive

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as mol...

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial  The Lancet

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes...

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial  Nature

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma  The ASCO Post

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide - UroToday

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide  UroToday

New Paper Alert: Adjuvant CDK4/6 Inhibitors: Promising or Problematic? A Critical Review of the E...

New Paper Alert: Adjuvant CDK4/6 Inhibitors: Promising or Problematic? A Critical Review of the Evidence  Oncodaily

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer - Ur...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer  UroToday

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration  Nature

Debate Over Adjuvant Therapy for Resectable Liver Cancer Divides Experts - Oncology News Central

Debate Over Adjuvant Therapy for Resectable Liver Cancer Divides Experts  Oncology News Central

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma  Cleveland Clinic

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis ...

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate  Nature

Synthetic Vaccine Adjuvant Shows Promise for Tuberculosis Vaccines - The American Association of ...

Synthetic Vaccine Adjuvant Shows Promise for Tuberculosis Vaccines  The American Association of Immunologists

Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Je...

Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Jean Hoffman-Censits  UroToday

Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monoth...

Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer  The Manila Times

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival a...

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis  Nature

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squam...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squamous Cell Carcinoma  ASCO Daily News

Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes - ACS Publications

Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes  ACS Publications

Wetmax - Model Plus - Adjuvant System - Environmental XPRT

Wetmax - Model Plus - Adjuvant System  Environmental XPRT

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a ...

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials  The Lancet

Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cel...

Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages  Nature

Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype? - ASCO Daily News

Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype?  ASCO Daily News

Locally Advanced Gastric Cancer: Adjuvant or Perioperative Therapy With D2 Resection - The ASCO Post

Locally Advanced Gastric Cancer: Adjuvant or Perioperative Therapy With D2 Resection  The ASCO Post

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions ...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions on How to Optimize Benefits  ASCO Daily News

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial ...

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial Infections and Exhibits Immunomodulatory Properties  ACS Publications

Adjuvant Cemiplimab Significantly Improves Disease-Free Survival in High-Risk Skin Cancer - The A...

Adjuvant Cemiplimab Significantly Improves Disease-Free Survival in High-Risk Skin Cancer  The American Journal of Managed Care® (AJMC®)

Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast ca...

Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast cancer patients  Nature

Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agoni...

Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant  ACS Publications

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC - OncLive

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC  OncLive

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today? - UroToday

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today?  UroToday

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized ...

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER) | npj Breast Cancer  Nature

Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma - OncLive

Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma  OncLive

Adjuvant Cemiplimab Improves DFS in High-Risk CSCC - Targeted Oncology

Adjuvant Cemiplimab Improves DFS in High-Risk CSCC  Targeted Oncology

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE T...

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE Trial  The ASCO Post

Adjuvant Ribociclib Wins EU Approval for HR+/HER2– Early Breast Cancer - OncLive

Adjuvant Ribociclib Wins EU Approval for HR+/HER2– Early Breast Cancer  OncLive

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma - The New Engla...

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - The New England Jou...

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer  The New England Journal of Medicine

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journa...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma  The New England Journal of Medicine

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine  National Institutes of Health (.gov)

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma - Nature

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma  Nature

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3...

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial  Nature

Engineered immunogen binding to alum adjuvant enhances humoral immunity - Nature

Engineered immunogen binding to alum adjuvant enhances humoral immunity  Nature

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - The New England Journal of...

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - The New England Jou...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  The New England Journal of Medicine

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - The New England J...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer  The New England Journal of Medicine

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - The New England Journal of Med...

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma  The New England Journal of Medicine

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer  Nature

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma - Nature

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma  Nature

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - The New England Journ...

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma  The New England Journal of Medicine

The scientific journey of a novel adjuvant (AS37) from bench to bedside - Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside  Nature

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - The New England Journ...

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma - The New England Journal of...

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma  The New England Journal of Medicine

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - The New England Journal of ...

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer  The New England Journal of Medicine

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC -...

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC  Nature

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - The New England Journal...

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy  The New England Journal of Medicine

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New Englan...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer  The New England Journal of Medicine

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - The New Englan...

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer  The New England Journal of Medicine

Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion - American Heart A...

Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion  American Heart Association Journals

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - The New England Jo...

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer  The New England Journal of Medicine

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer - The New England Journa...

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer  The New England Journal of Medicine

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally de...

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine  Nature

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National C...

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer  National Cancer Institute (.gov)